Mid-size biotech companies CEO compensation worldwide 2019

Among mid-sized biotech companies, United Therapeutics was ranked first in terms of compensation for their CEO, Martine Rothblatt, who received approximately 46 million U.S. dollars compensation during 2019.

Select CEO compensations provided by mid-size biotech firms in 2019 (in million U.S. dollars)

Company name (CEO name)	Compensation in million U.S. dollars
United Therapeutics (Martine Rothblatt)	45.64
BridgeBio (Neil Kumar)	26.33
Alkermes (Richard Pops)	14.64
Horizon Therapeutics (Timothy Walbert)	13.87
Bluebird bio (Nick Leschly)	13.15
Beigene (John Oyler)	12.58
Moderna (Stephane Bancel)	8.95

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

September 2020

More information

Region

Worldwide

Survey time period

2019

Number of respondents

base: 231 life sciences companies

Special properties

mid-size biotech companies

Supplementary notes

For the report, BioPharma Dive segmented the 231 companies into four groups by number of employees: small (fewer than 200), mid-sized (200 to 999), large (1,000 to 9,999) and greater than 10,000 (giant).

This statistic is for firms in the second category: mid-sized biotech companies with 200-999 employees.

CEO compensation includes base salary, cash bonuses and long-term stock and option awards, as described in annual proxy filings.

Citation formats